Giuseppini M U, Guiducci S, Bardelli M
Dipartimento di Ortopedia e Traumatologia Chirurgia O.S.M.A., Bagno a Ripoli, Firenze, Italia.
Minerva Med. 2010 Feb;101(1):49-58.
The patients undergoing major orthopedic surgery, which includes total hip replacement (THR), total knee replacement (TKR), and hip fracture surgery (HFS), represent a group that has a particularly high risk for venous thromboembolism (VTE), and routine thromboprophylaxis has been standard of care for >20 years. The following article summarizes data derived from numerous randomized clinical trials of thromboprophylaxis following THR, TKR, and HFS; areas of orthopedic surgery for which there are much less data, including knee arthroscopy and isolated lower extremity injuries, are also reviewed.
接受大型骨科手术的患者,包括全髋关节置换术(THR)、全膝关节置换术(TKR)和髋部骨折手术(HFS),是静脉血栓栓塞(VTE)风险特别高的群体,常规血栓预防已成为20多年来的标准治疗方法。以下文章总结了来自THR、TKR和HFS术后血栓预防的众多随机临床试验的数据;还对骨科手术领域的数据较少的领域进行了综述,包括膝关节镜检查和孤立的下肢损伤。